MD1375Z - Metodă de tratament al afecţiunilor inflamatorii ale ţesuturilor moi şi articulaţiilor - Google Patents

Metodă de tratament al afecţiunilor inflamatorii ale ţesuturilor moi şi articulaţiilor

Info

Publication number
MD1375Z
MD1375Z MDS20190004A MDS20190004A MD1375Z MD 1375 Z MD1375 Z MD 1375Z MD S20190004 A MDS20190004 A MD S20190004A MD S20190004 A MDS20190004 A MD S20190004A MD 1375 Z MD1375 Z MD 1375Z
Authority
MD
Moldova
Prior art keywords
articulations
inflammatory diseases
soft tissues
treating inflammatory
solution
Prior art date
Application number
MDS20190004A
Other languages
English (en)
Russian (ru)
Inventor
Виктор ГИКАВЫЙ
Янош КОРЕЦКИЙ
Олеся ПОПОВИЧ
Original Assignee
Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова filed Critical Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова
Priority to MDS20190004A priority Critical patent/MD1375Z/ro
Publication of MD1375Y publication Critical patent/MD1375Y/ro
Publication of MD1375Z publication Critical patent/MD1375Z/ro

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Invenţia se referă la medicina experimentală şi farmacologia clinică şi poate fi utilizată pentru tratamentul afecţiunilor inflamatorii ale ţesuturilor moi şi articulaţiilor la animalele de laborator.Esenţa invenţiei constă în aceea, că la şobolani se administrează intraperitoneal unimomentan 10 mg/kg soluţie de izopropilfosfit-S-izopropilizotiuroniu şi 10 mg/kg soluţie de diclofenac.
MDS20190004A 2019-01-22 2019-01-22 Metodă de tratament al afecţiunilor inflamatorii ale ţesuturilor moi şi articulaţiilor MD1375Z (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDS20190004A MD1375Z (ro) 2019-01-22 2019-01-22 Metodă de tratament al afecţiunilor inflamatorii ale ţesuturilor moi şi articulaţiilor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDS20190004A MD1375Z (ro) 2019-01-22 2019-01-22 Metodă de tratament al afecţiunilor inflamatorii ale ţesuturilor moi şi articulaţiilor

Publications (2)

Publication Number Publication Date
MD1375Y MD1375Y (ro) 2019-10-31
MD1375Z true MD1375Z (ro) 2020-05-31

Family

ID=68424456

Family Applications (1)

Application Number Title Priority Date Filing Date
MDS20190004A MD1375Z (ro) 2019-01-22 2019-01-22 Metodă de tratament al afecţiunilor inflamatorii ale ţesuturilor moi şi articulaţiilor

Country Status (1)

Country Link
MD (1) MD1375Z (ro)

Also Published As

Publication number Publication date
MD1375Y (ro) 2019-10-31

Similar Documents

Publication Publication Date Title
PH12018502634A1 (en) Topical compositions of apremilast
MA53496A (fr) Combinaisons pour le traitement de la stéatohépatite non alcoolique (nash)/maladie du foie gras non alcoolique (nafld) et de maladies associées
EA201992607A1 (ru) Твердые формы берберина урсодезоксихолата, их композиции и способы
PH12020551043A1 (en) Compounds, compositions, and methods for treatment of diseases involving acidic or hypoxic diseased tissues
IN2015DN00376A (ro)
JOP20220069A1 (ar) عوامل محللة لـ brd9 ثنائية الوظيفة وطرق لاستخدامها
WO2011102684A3 (ko) 태반 추출물을 포함하는 조성물
MX2024010140A (es) Nuevos metodos.
BRPI0819690B8 (pt) uso de uma composição compreendendo cisteamina ou cistamina, ou um sal farmaceuticamente aceitável das mesmas
EA200870254A1 (ru) Способ лечения воспалительных заболеваний
EA202090276A1 (ru) Фармацевтическая композиция для лечения анемии
MX2022012079A (es) Metodos y composiciones para mantener la salud renal.
WO2016090024A3 (en) Combination therapy for treatment of cancer
MA56019A (fr) Nouveaux composés et compositions pharmaceutiques associées pour le traitement de maladies
GB202010464D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
MX2021000127A (es) Formulaciones de un inhibidor de axl/mer.
MX2021006724A (es) Compuestos de halo-alilamina y uso de los mismos.
MX2023005971A (es) Metodos y composicion para las modificaciones de kras.
EP4389218A3 (en) Composition for treating joint disease and kit containing same
MX2022004382A (es) Metodos para promover la produccion de scfa por microbiota intestinal.
MD1375Y (ro) Metodă de tratament al afecţiunilor inflamatorii ale ţesuturilor moi şi articulaţiilor
WO2016130518A3 (en) Methods and compositions for treating muscle disease and disorders
MX2020005238A (es) Compuestos novedosos como inhibidores mpges-1.
BR112014001503A2 (pt) composições farmacêuticas compreendendo 4-bromo-n-(imidazolidin-2-ilideno)-1h-benzimidazol-5-amina para o tratamento de doenças de pele
MX2022012001A (es) Tratamiento preventivo de la migra?a.

Legal Events

Date Code Title Description
FG9Y Short term patent issued